Daphne Quimi Insider Trading $FOLD AMICUS THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daphne Quimi.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daphne Quimi. Daphne Quimi is Chief Financial Officer in AMICUS THERAPEUTICS, INC. ($FOLD) and Corporate Controller in AMICUS THERAPEUTICS INC ($FOLD) and SVP, Finance in AMICUS THERAPEUTICS INC ($FOLD) and Vice President Finance in AMICUS THERAPEUTICS INC ($FOLD) and VP Finance and Controller in AMICUS THERAPEUTICS INC ($FOLD).
Daphne Quimi in AMICUS THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Daphne Quimi: Chief Financial Officer, SVP, Finance, Vice President Finance, VP Finance and Controller, Corporate Controller
Holdings: 290,629 shares
Current Value: $1,749,587
Latest Transaction: Apr 08 2021
$FOLD Market Capitalization: $869.61M
$FOLD Previous Close: $6.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Daphne Quimi in AMICUS THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 08 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 19,295 | 0 | 290,629 | 271.3 K to 290.6 K (+7.11 %) |
| Mar 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.94 | 16,628 | 48,886 | 0 | |
| Mar 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 10.48 | 4,664 | 48,879 | 271,334 | 276 K to 271.3 K (-1.69 %) |
| Mar 09 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.94 | 16,628 | 48,886 | 275,998 | 259.4 K to 276 K (+6.41 %) |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 21.84 | 4,770 | 104,153 | 259,370 | 264.1 K to 259.4 K (-1.81 %) |
| Jan 20 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 9,502 | 0 | 264,140 | 254.6 K to 264.1 K (+3.73 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | A | 21.78 | 53,355 | 1,162,072 | 53,355 | |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 33,131 | 0 | 254,638 | 221.5 K to 254.6 K (+14.96 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.09 | 5,053 | 116,674 | 221,507 | 226.6 K to 221.5 K (-2.23 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.09 | 15,164 | 350,137 | 226,560 | 241.7 K to 226.6 K (-6.27 %) |
| Jan 05 2021 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.09 | 2,620 | 60,496 | 241,724 | 244.3 K to 241.7 K (-1.07 %) |
| Dec 23 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.94 | 5,000 | 14,700 | 16,628 | |
| Dec 23 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Sell | S | 24.09 | 5,000 | 120,474 | 244,344 | 249.3 K to 244.3 K (-2.01 %) |
| Dec 23 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.94 | 5,000 | 14,700 | 249,344 | 244.3 K to 249.3 K (+2.05 %) |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.45 | 6,892 | 16,885 | 0 | |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 3.53 | 4,379 | 15,458 | 0 | |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 4.38 | 7,550 | 33,069 | 0 | |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.94 | 11,500 | 33,810 | 21,628 | |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 23.86 | 4,156 | 99,162 | 244,344 | 248.5 K to 244.3 K (-1.67 %) |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.45 | 6,892 | 16,885 | 248,500 | 241.6 K to 248.5 K (+2.85 %) |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 3.53 | 4,379 | 15,458 | 241,608 | 237.2 K to 241.6 K (+1.85 %) |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 4.38 | 7,550 | 33,069 | 237,229 | 229.7 K to 237.2 K (+3.29 %) |
| Dec 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.94 | 11,500 | 33,810 | 229,679 | 218.2 K to 229.7 K (+5.27 %) |
| Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.45 | 11,000 | 26,950 | 6,892 | |
| Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.94 | 5,000 | 14,700 | 33,128 | |
| Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.45 | 11,000 | 26,950 | 218,179 | 207.2 K to 218.2 K (+5.31 %) |
| Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Sell | S | 14.02 | 5,000 | 70,099 | 207,179 | 212.2 K to 207.2 K (-2.36 %) |
| Oct 05 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.94 | 5,000 | 14,700 | 212,179 | 207.2 K to 212.2 K (+2.41 %) |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.94 | 6,872 | 20,204 | 28,128 | |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.45 | 13,000 | 31,850 | 17,892 | |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Sell | S | 15.47 | 6,872 | 106,326 | 207,179 | 214.1 K to 207.2 K (-3.21 %) |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.94 | 6,872 | 20,204 | 214,051 | 207.2 K to 214.1 K (+3.32 %) |
| Jul 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.45 | 13,000 | 31,850 | 207,179 | 194.2 K to 207.2 K (+6.69 %) |
| Jun 17 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 11.14 | 1,046 | 11,652 | 194,179 | 195.2 K to 194.2 K (-0.54 %) |
| Apr 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 4,803 | 0 | 195,225 | 190.4 K to 195.2 K (+2.52 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.46 | 12,065 | 114,135 | 190,422 | 202.5 K to 190.4 K (-5.96 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 24,496 | 0 | 202,487 | 178 K to 202.5 K (+13.76 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.46 | 12,065 | 114,135 | 190,422 | 202.5 K to 190.4 K (-5.96 %) |
| Jan 14 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 24,496 | 0 | 202,487 | 178 K to 202.5 K (+13.76 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 4.38 | 1,200 | 5,256 | 7,550 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | M | 2.52 | 9,822 | 24,751 | 0 | |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 4.38 | 1,200 | 5,256 | 177,991 | 176.8 K to 178 K (+0.68 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Buy | M | 2.52 | 9,822 | 24,751 | 176,791 | 167 K to 176.8 K (+5.88 %) |
| Jan 10 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Sell | S | 9.93 | 15,000 | 148,952 | 166,969 | 182 K to 167 K (-8.24 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.18 | 5,305 | 48,700 | 181,969 | 187.3 K to 182 K (-2.83 %) |
| Jan 06 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.55 | 7,113 | 67,929 | 187,274 | 194.4 K to 187.3 K (-3.66 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | A | 9.55 | 112,954 | 1,078,711 | 112,954 | |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 71,868 | 0 | 194,387 | 122.5 K to 194.4 K (+58.66 %) |
| Jan 03 2020 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 9.74 | 6,735 | 65,599 | 122,519 | 129.3 K to 122.5 K (-5.21 %) |
| Jun 18 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 11.35 | 1,046 | 11,872 | 129,254 | 130.3 K to 129.3 K (-0.80 %) |
| Apr 15 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 12,347 | 0 | 130,300 | 118 K to 130.3 K (+10.47 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Option Exercise | A | 10.04 | 88,154 | 885,066 | 88,154 | |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Payment of Exercise | F | 10.33 | 3,850 | 39,771 | 117,953 | 121.8 K to 118 K (-3.16 %) |
| Jan 10 2019 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Chief Financial Off ... | Grant | A | 0.00 | 57,471 | 0 | 121,803 | 64.3 K to 121.8 K (+89.34 %) |
| Mar 12 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | M | 5.96 | 8,750 | 52,150 | 0 | |
| Mar 12 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 15.00 | 8,750 | 131,250 | 64,332 | 73.1 K to 64.3 K (-11.97 %) |
| Mar 12 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Buy | M | 5.96 | 8,750 | 52,150 | 73,082 | 64.3 K to 73.1 K (+13.60 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | A | 15.67 | 18,224 | 285,570 | 18,224 | |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Payment of Exercise | F | 15.67 | 2,953 | 46,274 | 64,332 | 67.3 K to 64.3 K (-4.39 %) |
| Jan 05 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Grant | A | 0.00 | 12,609 | 0 | 67,285 | 54.7 K to 67.3 K (+23.06 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | M | 10.36 | 8,000 | 82,880 | 0 | |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 14.72 | 8,000 | 117,723 | 54,676 | 62.7 K to 54.7 K (-12.76 %) |
| Jan 04 2018 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Buy | M | 14.72 | 8,000 | 117,723 | 62,676 | 54.7 K to 62.7 K (+14.63 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | M | 10.21 | 7,000 | 71,470 | 0 | |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 14.25 | 7,000 | 99,740 | 54,676 | 61.7 K to 54.7 K (-11.35 %) |
| Oct 16 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Buy | M | 14.25 | 7,000 | 99,740 | 61,676 | 54.7 K to 61.7 K (+12.80 %) |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | A | 5.13 | 42,372 | 217,368 | 42,372 | |
| Jan 05 2017 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Grant | A | 0.00 | 30,487 | 0 | 54,676 | 24.2 K to 54.7 K (+126.04 %) |
| Nov 10 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | M | 2.45 | 2,858 | 7,002 | 30,892 | |
| Nov 10 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 8.00 | 2,858 | 22,864 | 24,189 | 27 K to 24.2 K (-10.57 %) |
| Nov 10 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Buy | M | 8.00 | 2,858 | 22,864 | 27,047 | 24.2 K to 27 K (+11.82 %) |
| Nov 10 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Sell | S | 8.00 | 5,688 | 45,504 | 24,189 | 29.9 K to 24.2 K (-19.04 %) |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Option Exercise | A | 6.10 | 35,000 | 213,500 | 35,000 | |
| Jun 17 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | SVP, Finance | Grant | A | 0.00 | 8,500 | 0 | 29,877 | 21.4 K to 29.9 K (+39.76 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | A | 9.03 | 50,000 | 451,500 | 50,000 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 0.00 | 25,000 | 0 | 0 | |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Payment of Exercise | F | 9.03 | 9,311 | 84,078 | 21,377 | 30.7 K to 21.4 K (-30.34 %) |
| Jan 06 2016 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Buy | M | 0.00 | 25,000 | 0 | 30,688 | 5.7 K to 30.7 K (+439.52 %) |
| Oct 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 2.45 | 11,250 | 27,563 | 33,750 | |
| Oct 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Sell | S | 13.13 | 11,250 | 147,761 | 5,688 | 16.9 K to 5.7 K (-66.42 %) |
| Oct 05 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Buy | M | 13.13 | 11,250 | 147,761 | 16,938 | 5.7 K to 16.9 K (+197.78 %) |
| Sep 16 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Sell | S | 18.08 | 2,500 | 45,200 | 5,688 | 8.2 K to 5.7 K (-30.53 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 2.52 | 1,690 | 4,259 | 9,822 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Option Exercise | M | 3.53 | 910 | 3,212 | 4,379 | |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Sell | S | 13.98 | 2,600 | 36,350 | 8,188 | 10.8 K to 8.2 K (-24.10 %) |
| Jul 01 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Vice President Fina ... | Buy | M | 13.98 | 2,600 | 36,350 | 10,788 | 8.2 K to 10.8 K (+31.75 %) |
| Jun 03 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | A | 12.28 | 45,000 | 552,600 | 45,000 | |
| May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Sell | S | 10.84 | 7,500 | 81,306 | 8,188 | 15.7 K to 8.2 K (-47.81 %) |
| May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Payment of Exercise | F | 10.80 | 9,312 | 100,570 | 15,688 | 25 K to 15.7 K (-37.25 %) |
| May 12 2015 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Buy | M | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Jan 07 2014 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | VP Finance and Cont ... | Option Exercise | A | 2.45 | 45,000 | 110,250 | 45,000 | |
| Jun 20 2013 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Corporate Controlle ... | Option Exercise | A | 2.52 | 16,250 | 40,950 | 16,250 | |
| Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Corporate Controlle ... | Option Exercise | A | 4.38 | 8,750 | 38,325 | 8,750 | |
| Jan 30 2013 | FOLD | AMICUS THERAPEUTIC ... | Quimi Daphne | Corporate Controlle ... | Option Exercise | A | 3.53 | 8,750 | 30,888 | 8,750 |
Page: 1